<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02868502</url>
  </required_header>
  <id_info>
    <org_study_id>MMC-0026-16</org_study_id>
    <nct_id>NCT02868502</nct_id>
  </id_info>
  <brief_title>Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma</brief_title>
  <official_title>The Effect of Trabeculectomy, Glaucoma Drainage Device, Cyclophotocoagulation, and Ocular Hypotensive Eye-drops on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of trabeculectomy, glaucoma drainage
      devices, cyclophotocoagulation and ocular hypotensive eye-drops on IOP elevation with
      postural change from the sitting to supine positions in eyes with open-angle glaucoma.

      Patients will be assigned to the different study groups according to their past ocular
      history. Interventions are similar to all study group and no medical therapy alteration will
      be made.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Visual impairment and blindness due to chronic progressive optic neuropathy developing from
      glaucoma are major health problems worldwide.

      Glaucoma is a progressive, potentially blinding disease, in which the only modifiable risk
      factor in intraocular pressure. In a significant proportion of patients, the disease
      progresses despite apparent IOP control(1-3).

      One factor which may explain some of this discrepancy is a fluctuation of the IOP during the
      day, which may be missed in a single visit to the ophthalmologist(4). Although this
      fluctuation depends to some degree on daily biologic rhythms and the specific type of
      glaucoma, a constant significant factor responsible for this effect is the IOP-dependent
      changes of body posture, from sitting or standing to lying down(5). Older studies have shown
      IOP postural changes in the range of 4-6 mmHg(6-8). Seeing how a typical patient may spend as
      much as a third of his life in the supine position, knowledge of IOP in this position, and
      its control, are of great importance in decreasing the chance for irreversible optic nerve
      damage.

      Several studies of Liu JH(9-11) have investigated the effect of hypotensive drops on
      nocturnal IOP. While prostaglandin analogues (PGA) and carbonic anhydrase inhibitors (CAI)
      seemed to have a significant nocturnal IOP lowering effect, the effect seen with beta
      blockers and alpha agonists was minimal. Mansouri et al.(12) recently showed that PGA seem to
      ï¬‚atten the IOP-related increase when moving from the sitting to the supine position at
      nocturnal period, without effecting other circadian IOP-related patterns.

      Hirooka Kazuyuki investigated the effect of trabeculectomy on the IOP fluctuations caused by
      postural changes(13-14). He showed that successful trabeculectomy, which didn't require
      needling, have significantly decreased the posture-induced IOP changes to less than 3 mmHg.

      To the best of our knowledge there is no data regarding the effect of glaucoma drainage
      devices and cyclophotocoagulation on supine IOP.

      The purpose of this study is to investigate the effect of different IOP lowering methods,
      including trabeculectomy, glaucoma drainage devices, cyclophotocoagulation and ocular
      hypotensive eye-drops on IOP with postural change from the sitting to supine positions in
      eyes with open-angle glaucoma.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurements of Intra Ocular Pressure Fluctuation with Postural Change in Eyes with Open-angle Glaucoma and Ocular Hypertension, compared to healthy subjects</measure>
    <time_frame>Change from baseline 5 minutes following position change</time_frame>
    <description>Interventions are similar for all study groups: The subject will be instructed to stay in a sitting position for 5 minutes. A topical anesthetic eye drop (oxybuprocaine hydrochloride 0.4%) will then be installed in the study eye (necessary procedure made in all IOP examinations as a regular procedure) and the IOP will be measured, in the following order by 4 tonometers: Goldmann tonometer, Pneumatonometer, Tonopen XL, ICare rebound tonometer. The subject will then lie supine for 5 minutes, afterwards will turn to the lateral decubitus position and IOP will be measured again using the same tonometers in the same manner.
The difference between IOP in the sitting and lying body positions will be assessed and compared to the control group.</description>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>Trabeculectomy</arm_group_label>
    <description>Subjects with OAG s/p Trabeculectomy. IOP measurement in different positions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ahmed Glaucoma Valve implantation</arm_group_label>
    <description>Subjects with OAG s/p Ahmed valve implantation. IOP measurement in different positions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cyclophotocoagulation</arm_group_label>
    <description>Subjects with OAG s/p Cyclophotocoagulation. IOP measurement in different positions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ocular hypotensive eye drops</arm_group_label>
    <description>Subjects with OAG treated with ocular hypotensive eye drops and no ocular surgical hypotensive treatments.
IOP measurement in different positions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ocular Hypertension</arm_group_label>
    <description>Subjects with no evidence of glaucomatous damage, but with IOP measurements above 21 mmHg..
IOP measurement in different positions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Subjects with healthy eyes, apart for refraction errors, post cataract surgery, strabismus or amblyopia.
IOP measurement in different positions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Goldmann tonometer</intervention_name>
    <description>IOP measurement in the sitting position and lateral decubitus</description>
    <arm_group_label>Trabeculectomy</arm_group_label>
    <arm_group_label>Ahmed Glaucoma Valve implantation</arm_group_label>
    <arm_group_label>Cyclophotocoagulation</arm_group_label>
    <arm_group_label>Ocular hypotensive eye drops</arm_group_label>
    <arm_group_label>Ocular Hypertension</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pneumatonometer</intervention_name>
    <description>IOP measurement in the sitting position and lateral decubitus</description>
    <arm_group_label>Trabeculectomy</arm_group_label>
    <arm_group_label>Ahmed Glaucoma Valve implantation</arm_group_label>
    <arm_group_label>Cyclophotocoagulation</arm_group_label>
    <arm_group_label>Ocular hypotensive eye drops</arm_group_label>
    <arm_group_label>Ocular Hypertension</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tonopen XL</intervention_name>
    <description>IOP measurement in the sitting position and lateral decubitus</description>
    <arm_group_label>Trabeculectomy</arm_group_label>
    <arm_group_label>Ahmed Glaucoma Valve implantation</arm_group_label>
    <arm_group_label>Cyclophotocoagulation</arm_group_label>
    <arm_group_label>Ocular hypotensive eye drops</arm_group_label>
    <arm_group_label>Ocular Hypertension</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICare rebound tonometer</intervention_name>
    <description>IOP measurement in the sitting position and lateral decubitus</description>
    <arm_group_label>Trabeculectomy</arm_group_label>
    <arm_group_label>Ahmed Glaucoma Valve implantation</arm_group_label>
    <arm_group_label>Cyclophotocoagulation</arm_group_label>
    <arm_group_label>Ocular hypotensive eye drops</arm_group_label>
    <arm_group_label>Ocular Hypertension</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        subjects with open angle glaucoma with past ocular history of surgical treatment
        (trabeculectomy, implantation of an Ahmed glaucoma drainage device or
        cyclophotocoagulation) or are using ocular hypotensive eye drops and subjects with ocular
        hypertension.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  OAG patients

          -  Ocular Hypertension (OHT) patients

          -  Healthy subjects, without any ocular pathology (except for refraction errors, past
             cataract surgery, strabismus or amblyopia).

        Exclusion Criteria:

          -  Other intraocular surgeries within the past 3 months

          -  Illness effecting episcleral venous pressure, such as superior vena cava syndrome,
             thyroid eye disease, orbital masses

          -  Patients who are unable to maintain supine position for 15 minutes

          -  Corneal abnormalities: epithelial pathologies, corneal infection, corneal erosions,
             corneal scars, keratoconus, S/P corneal transplantation (lamellar/full thickness)

          -  Hypersensitivity to oxybuprocaine hydrochloride
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avner Belkin, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meir Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ortal Fogel Tempelhof, M.D</last_name>
    <phone>+972528518303</phone>
    <email>talifog@gmail.com</email>
  </overall_contact>
  <reference>
    <citation>Schulzer M, Mikelberg FS, Drance SM. Some observations on the relation between intraocular pressure reduction and the progression of glaucomatous visual loss. Br J Ophthalmol. 1987 Jul;71(7):486-8.</citation>
    <PMID>3651360</PMID>
  </reference>
  <reference>
    <citation>Flammer J, Robert Y, Gloor B. Influence of pindolol and timolol treatment on the visual fields of glaucoma patients. J Ocul Pharmacol. 1986 Fall;2(4):305-11.</citation>
    <PMID>3503114</PMID>
  </reference>
  <reference>
    <citation>Kidd MN, O'Connor M. Progression of field loss after trabeculectomy: a five-year follow-up. Br J Ophthalmol. 1985 Nov;69(11):827-31.</citation>
    <PMID>4063249</PMID>
  </reference>
  <reference>
    <citation>Barkana Y, Anis S, Liebmann J, Tello C, Ritch R. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol. 2006 Jun;124(6):793-7.</citation>
    <PMID>16769832</PMID>
  </reference>
  <reference>
    <citation>Barkana Y, Gutfreund S. Measurement of the difference in intraocular pressure between the sitting and lying body positions in healthy subjects: direct comparison of the Icare Pro with the Goldmann applanation tonometer, Pneumatonometer and Tonopen XL. Clin Exp Ophthalmol. 2014 Sep-Oct;42(7):608-14. doi: 10.1111/ceo.12272. Epub 2014 Jan 13.</citation>
    <PMID>24299102</PMID>
  </reference>
  <reference>
    <citation>Weber AK, Price J. Pressure differential of intraocular pressure measured between supine and sitting position. Ann Ophthalmol. 1981 Mar;13(3):323-6.</citation>
    <PMID>7258940</PMID>
  </reference>
  <reference>
    <citation>Buchanan RA, Williams TD. Intraocular pressure, ocular pulse pressure, and body position. Am J Optom Physiol Opt. 1985 Jan;62(1):59-62.</citation>
    <PMID>3976837</PMID>
  </reference>
  <reference>
    <citation>Yamabayashi S, Aguilar RN, Hosoda M, Tsukahara S. Postural change of intraocular and blood pressures in ocular hypertension and low tension glaucoma. Br J Ophthalmol. 1991 Nov;75(11):652-5.</citation>
    <PMID>1751457</PMID>
  </reference>
  <reference>
    <citation>Liu JH, Kripke DF, Weinreb RN. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure. Am J Ophthalmol. 2004 Sep;138(3):389-95.</citation>
    <PMID>15364220</PMID>
  </reference>
  <reference>
    <citation>Liu JH, Medeiros FA, Slight JR, Weinreb RN. Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure. Ophthalmology. 2010 Nov;117(11):2075-9. doi: 10.1016/j.ophtha.2010.03.026. Epub 2010 Jul 21.</citation>
    <PMID>20663566</PMID>
  </reference>
  <reference>
    <citation>Tung JD, Tafreshi A, Weinreb RN, Slight JR, Medeiros FA, Liu JH. Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure. BMJ Open. 2012 Aug 23;2(4). pii: e001106. doi: 10.1136/bmjopen-2012-001106. Print 2012.</citation>
    <PMID>22918671</PMID>
  </reference>
  <reference>
    <citation>Mansouri K, Medeiros FA, Weinreb RN. Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor. Clin Exp Ophthalmol. 2015 Dec;43(9):787-95. doi: 10.1111/ceo.12567. Epub 2015 Aug 16.</citation>
    <PMID>26152693</PMID>
  </reference>
  <reference>
    <citation>Hirooka K, Takenaka H, Baba T, Takagishi M, Mizote M, Shiraga F. Effect of trabeculectomy on intraocular pressure fluctuation with postural change in eyes with open-angle glaucoma. J Glaucoma. 2009 Dec;18(9):689-91. doi: 10.1097/IJG.0b013e31819c49f4.</citation>
    <PMID>20010249</PMID>
  </reference>
  <reference>
    <citation>Hirooka K, Tenkumo K, Nitta E, Sato S. Correlation between Intraocular Pressure Fluctuation with Postural Change and Postoperative Intraocular Pressure in Relation to the Time Course after Trabeculectomy. J Ophthalmol. 2014;2014:801967. doi: 10.1155/2014/801967. Epub 2014 Jul 17.</citation>
    <PMID>25136454</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2016</study_first_submitted>
  <study_first_submitted_qc>August 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2016</study_first_posted>
  <last_update_submitted>August 14, 2016</last_update_submitted>
  <last_update_submitted_qc>August 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>Avner Belkin</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>Open Angle Glaucoma</keyword>
  <keyword>Intra Ocular Pressure</keyword>
  <keyword>Ocular Hypotensive Drops</keyword>
  <keyword>Trabeculectomy</keyword>
  <keyword>Cyclophotocoagulation</keyword>
  <keyword>Glaucoma Drainage Device</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
    <mesh_term>Antihypertensive Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

